Evidence map›Paper›PMID 34216267›Full record

ReviewArchives of virology2021

Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.

Tirth Uprety, Dan Wang, Feng Li

Abstract readReview
In one paragraph

Review in Archives of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tirth UpretyDepartment of Veterinary Science, M. H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, 40546, USA.
Dan WangDepartment of Veterinary Science, M. H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, 40546, USA.
Feng LiDepartment of Veterinary Science, M. H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, 40546, USA. Feng.Li@uky.edu.ORCID http://orcid.org/0000-0002-8904-2893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rotaviruses are segmented double-stranded RNA viruses with a high frequency of gene reassortment, and they are a leading cause of global diarrheal deaths in children less than 5 years old. Two-thirds of rotavirus-associated deaths occur in low-income countries. Currently, the available vaccines in developing countries have lower efficacy in children than those in developed countries. Due to added safety concerns and the high cost of current vaccines, there is a need to develop cost-effective next-generation vaccines with improved safety and efficacy. The reverse genetics system (RGS) is a powerful tool for investigating viral protein functions and developing novel vaccines. Recently, an entirely plasmid-based RGS has been developed for several rotaviruses, and this technological advancement has significantly facilitated novel rotavirus research. Here, we review the recently developed RGS platform and discuss its application in studying infection biology, gene reassortment, and development of vaccines against rotavirus disease.

Indexed as

Reverse GeneticsAnimalsChild, PreschoolCost-Benefit AnalysisDiarrheaHost-Pathogen InteractionsHumansPlasmidsRNA, ViralRotavirusRotavirus InfectionsRotavirus VaccinesViral ProteinsRNA, ViralRotavirus VaccinesViral Proteins

Identifiers

PMID34216267
PMCPMC8254061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.